Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
LLY
Eli Lilly and Company
Lilly is a large, diversified global pharmaceutical company with a core high-revenue portfolio.
|
$1.00T |
$1065.49
+0.55%
|
|
JNJ
Johnson & Johnson
Johnson & Johnson's portfolio includes multiple monoclonal antibody therapeutics (e.g., DARZALEX, CARVYKTI, TECVAYLI, TALVEY) across oncology and immunology.
|
$491.06B |
$204.65
+0.37%
|
|
ABBV
AbbVie Inc.
AbbVie directly commercializes monoclonal antibody therapeutics (e.g., Skyrizi) as a core immunology asset.
|
$417.40B |
$230.44
-2.47%
|
|
UNH
UnitedHealth Group Incorporated
UNH is primarily a health insurer and provides medical benefit plans through UnitedHealthcare.
|
$289.79B |
$320.42
+0.14%
|
|
AZN
AstraZeneca PLC
AZN is a large-cap pharmaceutical company with a diversified, global drug portfolio and a robust R&D pipeline.
|
$282.10B |
$91.75
+0.82%
|
|
MRK
Merck & Co., Inc.
The company markets vaccines (Capvaxive) and has historical Gardasil sales, making vaccines a core product category.
|
$244.18B |
$101.08
+3.40%
|
|
ABT
Abbott Laboratories
Abbott's cardiology device portfolio includes leadless pacemakers (AVEIR), MitraClip/TMVR systems and other interventional devices, representing core revenue drivers in Cardiology Devices.
|
$222.97B |
$128.63
+0.41%
|
|
TMO
Thermo Fisher Scientific Inc.
Thermo Fisher directly manufactures and sells diagnostic instruments and equipment used in clinical labs.
|
$221.84B |
$585.76
-0.29%
|
|
NVO
Novo Nordisk A/S
Novo Nordisk is a leading large-cap pharmaceutical company with blockbuster GLP-1 products Wegovy and Ozempic, a core driver of its revenue and growth.
|
$214.81B |
$45.14
-5.23%
|
|
ISRG
Intuitive Surgical, Inc.
Intuitive Surgical directly manufactures robotic surgical systems and instruments, i.e., core surgical equipment.
|
$201.32B |
$568.35
+1.20%
|
|
AMGN
Amgen Inc.
Amgen's portfolio includes monoclonal antibody therapeutics such as Repatha and tezepelumab (TEZSPIRE).
|
$181.72B |
$333.89
-1.08%
|
|
DHR
Danaher Corporation
Danaher directly sells diagnostic equipment/instruments (e.g., Cepheid and Beckman Coulter diagnostics platforms like DxC 500i, DXi 9000).
|
$162.82B |
$226.60
-0.35%
|
|
GILD
Gilead Sciences, Inc.
Trodelvy is a TROP2-targeted antibody-drug conjugate (ADC), a core oncology modality.
|
$157.14B |
$125.76
-0.69%
|
Showing page 1 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
